drugset / Trial / NCT01008553

A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome

NCT01008553 ↗

Phase 3 Completed 258 enrolled Janssen Pharmaceutical K.K.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of fentanyl in opioid-naive participants with post-herpetic neuralgia, complex regional pain syndrome or post-operative pain syndrome who cannot obtain a sufficient analgesic effect by the treatment of non-opioid analgesics (drug used to control pain).

Timeline

Start
2008-12
Primary completion
2010-03
Completion
2010-03

Outcome

Met primary endpoint

paper In the N02 study, both primary efficacy (P = 0.0003) and VAS (8.7 [2.4, 15.0] mm, P = 0.0071) results showed that fentanyl was more effective than placebo. PMID 26359327 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 12.5 ug Other
Subject Fentanyl Other / unclassified 50 ug Other